Tech Company Acquirers

Novo Nordisk

Looking for who was acquired by Novo Nordisk? Corvidia Therapeutics joined this biopharmaceutical company.

Company Overview

Company Name
Novo Nordisk
Company Status
Publicly-held
Industry
Biopharmaceutical
Acquisitions

Contact Information

Mailing Address
Novo Allé 1
Bagsvaerd, 2880
Denmark
Email Address
Not Recorded

Company Background Information

Overview
We are a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease.
Profile
Novo Nordisk LinkedIn Company Profile
Social Media
Novo Nordisk Company Twitter Account
Company News
Novo Nordisk News
Facebook
Novo Nordisk on Facebook
YouTube
Novo Nordisk on YouTube
Last Transaction
6/11/2020

Acquisitions By Novo Nordisk

Date
Company
Amount
6/11/2020
$2,100,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Lars Jørgensen
  Lars Jørgensen LinkedIn Profile  Lars Jørgensen Twitter Account  Lars Jørgensen News  Lars Jørgensen on Facebook
Chief Financial Officer
Karsten Knudsen
  Karsten Knudsen LinkedIn Profile  Karsten Knudsen Twitter Account  Karsten Knudsen News  Karsten Knudsen on Facebook
Chief Scientific Officer
Mads Thomsen
  Mads Thomsen LinkedIn Profile  Mads Thomsen Twitter Account  Mads Thomsen News  Mads Thomsen on Facebook
Vice President
Ludovic Helfgott
  Ludovic Helfgott LinkedIn Profile  Ludovic Helfgott Twitter Account  Ludovic Helfgott News  Ludovic Helfgott on Facebook
VP - Human Resources
Monique Carter
  Monique Carter LinkedIn Profile  Monique Carter Twitter Account  Monique Carter News  Monique Carter on Facebook
VP - Operations
Maziar Doustdar
  Maziar Doustdar LinkedIn Profile  Maziar Doustdar Twitter Account  Maziar Doustdar News  Maziar Doustdar on Facebook
VP - Operations
Douglas Langa
  Douglas Langa LinkedIn Profile  Douglas Langa Twitter Account  Douglas Langa News  Douglas Langa on Facebook
VP - Regulatory Affairs
Camilla Sylvest
  Camilla Sylvest LinkedIn Profile  Camilla Sylvest Twitter Account  Camilla Sylvest News  Camilla Sylvest on Facebook
VP - Regulatory Affairs
Henrik Wulff
  Henrik Wulff LinkedIn Profile  Henrik Wulff Twitter Account  Henrik Wulff News  Henrik Wulff on Facebook


 

 

Browse more tech company acquirers:

Noven Pharmaceuticals | Novozymes A/S

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary